TipRanks
Lumibird SA (GB:0FRI)
LSE:0FRI

Lumibird SA (0FRI) Price & Analysis

0 Followers

0FRI Stock Chart & Stats

€27.30
-€0.30(-1.10%)
At close: 4:00 PM EDT
€27.30
-€0.30(-1.10%)

Bulls Say, Bears Say

Bulls Say
Steady Revenue GrowthRevenue growth of 8.9% and a history of steady expansion support ongoing demand for Lumibird’s laser and imaging offerings. Although recent growth has moderated to low single digits, the multi-year trend still provides a durable base for scale.
Improved ProfitabilityNet margin improved to about 6.2% in 2025 from 2.7% in 2024, while operating margin also increased. This earnings inflection suggests better execution or mix and gives the business more internal capacity to fund development, even though consistency remains unproven.
Manageable LeverageDebt-to-equity ended 2025 at about 0.71, within the pack’s historical 0.54–0.81 range, while equity and assets expanded. This suggests leverage is manageable and supports operating scale, although it is not light enough to remove balance-sheet risk.
Bears Say
Volatile Free Cash FlowOperating cash flow is positive but inconsistent, while free cash flow was materially negative in 2022 and 2023 before recovering. This history indicates working-capital swings and/or meaningful capex needs, which can limit dependable self-funded growth.
Weak Cash Conversion2025 free cash flow was only about 30% of net income. Weak conversion means reported earnings may not translate reliably into deployable cash, reducing flexibility for investment, debt reduction, or shareholder returns over the medium term.
Moderating Growth And Margin VisibilityRevenue growth has slowed to low single digits in 2024–2025 after stronger earlier expansion, while margins have varied across years. The reported zero 2025 gross profit also reduces confidence in the quality and durability of the margin improvement.

0FRI FAQ

What was Lumibird SA’s price range in the past 12 months?
Lumibird SA lowest share price was €18.75 and its highest was €28.65 in the past 12 months.
    What is Lumibird SA’s market cap?
    Lumibird SA’s market cap is €579.19M.
      When is Lumibird SA’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Lumibird SA’s earnings last quarter?
      Currently, no data Available
      Is Lumibird SA overvalued?
      According to Wall Street analysts Lumibird SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Lumibird SA pay dividends?
        Lumibird SA pays a Notavailable dividend of €0.374 which represents an annual dividend yield of 1.49%. See more information on Lumibird SA dividends here
          What is Lumibird SA’s EPS estimate?
          Lumibird SA’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Lumibird SA have?
          Lumibird SA has 22,466,883 shares outstanding.
            What happened to Lumibird SA’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Lumibird SA?
            Currently, no hedge funds are holding shares in GB:0FRI
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              Lumibird SA

              A global leader, Lumibird S.A. specializes in the development, manufacturing, and distribution of a wide array of laser technologies. Its sophisticated laser products are deployed worldwide across scientific, industrial, and medical sectors. The company's operations are divided into two key segments: Photonics and Medical. Within its Photonics division, Lumibird offers an extensive portfolio, including solid-state lasers, high-power laser diodes, fiber lasers, and related amplifiers and components. This segment also provides advanced photonics solutions for time-of-flight LiDAR, range-finding, and Doppler LiDAR systems for wind measurement. These offerings are critical for industrial and scientific advancements, defense and space operations, and diverse LiDAR sensing needs. Concurrently, the Medical division delivers comprehensive medical and ophthalmological solutions, encompassing everything from diagnosis to laser-based therapies. Established in 1970, Lumibird S.A. maintains its corporate headquarters in Lannion, France.

              Lumibird SA (0FRI) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              bioMerieux
              MAUNA KEA TECHNOLOGIES
              Sartorius Stedim Biotech
              Theraclion SA
              Median Technologies
              Popular Stocks